# PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

> **NCT05156515** · NA · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 20 (estimated)

## Conditions studied

- Lung Cancer
- Melanoma
- PD-L1
- PET/CT

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-THP-APN09

## Key facts

- **NCT ID:** NCT05156515
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-09
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05156515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05156515, "PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05156515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*